Introduction
A large proportion of patients with infectious mononucleosis (IM) have
abnormal liver function tests (LFT) at presentation. There is no
guideline regarding the management and follow-up of these patients. Some
patients also have abdominal ultrasound due to deranged LFT, the need
for this practice is unclear. The aim of this systematic review was to
evaluate the evidence base on LFT assessment in IM, time to resolution
of derangement, and the role of abdominal ultrasound.